Phenomic AI Companies
Phenomic AI uses artificial intelligence to analyze phenotypes in complex disease models, including high-content co-culture and 3D assays, to discover and optimize therapeutics directly against phenotypic assays. The company's drug discovery platform makes it easier for pharmaceutical companies to discover drugs.
Investors
.png)
.png)
Founded Date:
2017-01-01
Technology:
Artificial Intelligence, Biotechnology, Information Technology, Machine Learning
Funding Status:
Seed
Total Funding:
11391214.0
Employee Number:
5
Headquarters:
Toronto, Ontario, Canada
Last Funding Date:
2020-10-07
Investors Number:
13.0
Last Funding Type:
Seed
Estimated Revenue:
$6 million
Industry:
BioTech & Health Care